Home page > Products > Curosurf®

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Curosurf®

active ingredient: Poractant alfa
Patient leaflet
Summary of Product Characteristics

80 mg /ml, suspension for intratracheal and bronchoalveolar administration
Fraction of phospholipids from the lungs of the pig

 

Report adverse drug reaction.

  

If you are a doctor please login ....

Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and scope of treatment is appropriate.